Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.

Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.

The Collaborative Group on Hormonal Factors in Breast Cancer has brought together and reanalysed the worldwide epidemiological evidence on breast cancer risk and use of hormonal contraceptives. Original data from 54 studies, representing about 90% of the information available on the topic, were coll...

Full description

Bibliographic Details
Main Author:	Beral, V
Format:	Journal article
Language:	English
Published:	1996

Similar Items

Breast cancer and hormonal contraceptives: Further results
by: Calle, E, et al.
Published: (1996)

Breast cancer and combined oral contraceptives: Results from the Collaborative Group on Hormonal Factors in Breast Cancer
by: Beral, V, et al.
Published: (1998)

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
by: Beral, V
Published: (1997)

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer.
by: Cancer, C
Published: (1996)

Breast cancer and hormone exposure - Reply
by: Beral, V, et al.
Published: (1996)

Hormones and breast cancer.
by: Key, T, et al.
Published: (2002)

Impact of hormone replacement therapy on breast cancer
by: Gathani, T, et al.
Published: (2010)

Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies
by: Calle, E, et al.
Published: (1996)

Breast cancer and hormone exposure.
by: Grant, E, et al.
Published: (1996)

Breast cancer and hormone-replacement therapy in the Million Women Study.
by: Beral, V
Published: (2003)

Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct.
by: Banks, E, et al.
Published: (2004)

Endogenous hormones and the aetiology of breast cancer.
by: Key, T, et al.
Published: (1999)

Childbearing, oral contraceptive use, and breast cancer.
by: Beral, V, et al.
Published: (1993)

CHILDBEARING, ORAL-CONTRACEPTIVE USE, AND BREAST-CANCER
by: Beral, V, et al.
Published: (1993)

Hormone replacement therapy increase breast cancer incidence and may increase breast cancer mortality in postmenopausal women
by: Beral, V, et al.
Published: (2004)

Menopausal hormone therapy and 20-year breast cancer mortality
by: Beral, V, et al.
Published: (2019)

Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case–control study and meta-analysis
by: Fitzpatrick, D, et al.
Published: (2023)

Oral contraceptives and breast cancer.
by: McPherson, K, et al.
Published: (1983)

Cervical cancer and use of hormonal contraceptives: a systematic review.
by: Smith, J, et al.
Published: (2003)

Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct (multiple letters)
by: Banks, E, et al.
Published: (2004)

Breast cancer and hormone-replacement therapy: the Million Women Study - Reply
by: Beral, V, et al.
Published: (2003)

Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
by: Beral, V, et al.
Published: (1997)

Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
by: Beral, V, et al.
Published: (2011)

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
by: Beral, V, et al.
Published: (1997)

Hormonal and other factors in relation to survival among breast cancer patients.
by: Reeves, G, et al.
Published: (2000)

Sex hormones and cancer.
by: Key, T, et al.
Published: (1992)

Breast cancer and hormone-replacement therapy: the Million Women Study.
by: Bliss, J, et al.
Published: (2003)

Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
by: Kaaks, R, et al.
Published: (2014)

Hormone receptor status of breast cancers and other prognostic factors in two study centres
by: Hassan, Mohammad Syauki
Published: (2010)

Hormone receptor status of breast cancers and other prognostic factors in two study centres
by: Hassan, Mohammad Syauki
Published: (2010)

Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia.
by: Canfell, K, et al.
Published: (2008)

Added value of serum hormone measurements in risk prediction models for breast cancer for women not using exogenous hormones: Results from the EPIC cohort.
by: Husing, A, et al.
Published: (2017)

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
by: Reeves, G, et al.
Published: (2006)

Age-specific differences in the relationship between oral contraceptive use and breast cancer.
by: Wingo, P, et al.
Published: (1993)

Age-specific differences in the relationship between oral contraceptive use and breast cancer.
by: Wingo, P, et al.
Published: (1991)

AGE-SPECIFIC DIFFERENCES IN THE RELATION BETWEEN ORAL-CONTRACEPTIVE USE AND BREAST-CANCER
by: Wingo, P, et al.
Published: (1990)

Breast cancer and oral contraceptives--the evidence so far.
by: Reeves, G
Published: (1996)

Oral contraceptives and the small increased risk of breast cancer
by: Hunter, D
Published: (2017)

Oral contraceptives and the small increased risk of breast cancer
by: Hunter, D
Published: (2017)

BREAST-CANCER AND THE ESTROGEN CONTENT OF ORAL-CONTRACEPTIVES - REPLY
by: Mcpherson, K, et al.
Published: (1984)